Promising Results in Asthma Treatment Using Engineered T Cells
Groundbreaking study in Nature Immunology shows promising results in treating asthma with engineered long-lived and multifunctional T cells. Research led by Gang Jin demonstrates durable remission of asthma in mice with a single infusion. This innovative approach offers hope for the future of asthma treatment and the potential of immunotherapy in managing respiratory diseases.
New FUME-TCRseq Technique Enables Study of Immune Response to Cancer Using Archived Tissue Samples
Researchers have developed a new technique, FUME-TCRseq, which enables the study of immune response to cancer using archived tissue samples. This breakthrough could significantly impact the understanding of the immune system’s role in cancer development, progression, and treatment.
CAR T Cells Show Potential in Treating Age-Related Diseases, Study Finds
Recent research led by Memorial Sloan Kettering Cancer Center and Cold Spring Harbor Laboratory has revealed the potential of Chimeric Antigen Receptor (CAR) T cells in treating diseases related to aging. The study suggests that these engineered immune cells could…
Breakthrough in Anti-Ageing Research
A recent breakthrough in anti-ageing research has uncovered a potential key to slowing down the ageing process, offering the prospect of a longer and healthier life. Published in Nature Aging, the study conducted by scientists in the USA has revealed…